- Home
- CNVS vs OKYO Comparison
CNVS vs OKYO Comparison
Compare CNVS & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNVS
- OKYO
- Stock Information
- Founded
- CNVS 2000
- OKYO 2007
- Country
- CNVS United States
- OKYO United Kingdom
- Employees
- CNVS N/A
- OKYO N/A
- Industry
- CNVS Consumer Electronics/Video Chains
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNVS Consumer Discretionary
- OKYO Health Care
- Exchange
- CNVS Nasdaq
- OKYO Nasdaq
- Market Cap
- CNVS 102.4M
- OKYO 85.0M
- IPO Year
- CNVS 2003
- OKYO 2022
- Fundamental
- Price
- CNVS $3.27
- OKYO $2.13
- Analyst Decision
- CNVS Buy
- OKYO Strong Buy
- Analyst Count
- CNVS 1
- OKYO 1
- Target Price
- CNVS $10.00
- OKYO $7.00
- AVG Volume (30 Days)
- CNVS 383.1K
- OKYO 56.1K
- Earning Date
- CNVS 11-13-2025
- OKYO 07-18-2025
- Dividend Yield
- CNVS N/A
- OKYO N/A
- EPS Growth
- CNVS N/A
- OKYO N/A
- EPS
- CNVS 0.13
- OKYO N/A
- Revenue
- CNVS $80,173,000.00
- OKYO N/A
- Revenue This Year
- CNVS $1.28
- OKYO N/A
- Revenue Next Year
- CNVS N/A
- OKYO N/A
- P/E Ratio
- CNVS $24.78
- OKYO N/A
- Revenue Growth
- CNVS 77.07
- OKYO N/A
- 52 Week Low
- CNVS $0.79
- OKYO $0.90
- 52 Week High
- CNVS $7.39
- OKYO $3.35
- Technical
- Relative Strength Index (RSI)
- CNVS 28.84
- OKYO 36.03
- Support Level
- CNVS $3.29
- OKYO $2.07
- Resistance Level
- CNVS $3.91
- OKYO $2.39
- Average True Range (ATR)
- CNVS 0.26
- OKYO 0.14
- MACD
- CNVS -0.06
- OKYO -0.00
- Stochastic Oscillator
- CNVS 3.27
- OKYO 17.50
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.